Print ISSN:-2581-5555
Online ISSN:-2456-9542
CODEN : IIJCDU
Original Article
Author Details :
Volume : 7, Issue : 3, Year : 2022
Article Page : 141-145
https://doi.org/10.18231/j.ijcaap.2022.029
Abstract
Urinary tract infection is one of the most common bacterial disease found in all age groups and has become a major health problem in developing countries. UTI’s are treated with various antibiotics but extensive and inappropriate use of antibiotics promotes the development of antibiotic resistance among uropathogenic bacteria and also responsible for emerging multidrug resistant strains. The development of drug resistance among uropathogens made treatment of UTI is difficult which has led to the search of new source of antimicrobial agent that act against these uropathogenic bacteria. The ethnomedicinal plants are natural resource and known as traditional healer, which can use for successful therapy of various infectious diseases. In present study, we observed antibacterial potential of methanolic root extract of two medicinal plants and against urinary tract infection causing uropathogens. For this 120 urine samples of suspected patients were collected from different hospitals of Ujjain and processed in SRL laboratory Ujjain Center. It was seen that 72 samples were positive and showing significant bacteriuria and prevalence of UTI was 60%. The major causal bacterial agent was , and and their frequency of occurrence was 37.5%, 25%, 15.2%, 13.8% and 9.7%. The antibacterial effect of methanolic plant extracts of both and was determined against isolated uropathogens by disc diffusion method. The effectiveness of both and was observed and it was found that they have effective antibacterial activity against uropathogens so they can be used as alternative drug against uropathogens.
Keywords: Escherichia coli, Ethnomedicinal plants, Antibacterial effect, Healer, Plant extracts
How to cite : Bhonsle K, Vyas A, Vyas H, Abhiraj, Hemwani K, Antibacterial activity of methanolic root extracts of Asparagus racemosus and Withania somnifera against uropathogens causing urinary tract infection. IP Int J Compr Adv Pharmacol 2022;7(3):141-145
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.